About NextCure  Inc
Ticker
info
NXTC
Trading on
info
NASDAQ
ISIN
info
US65343E1082
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Michael S. Richman MSBA
Headquarters
info
9000 Virginia Manor Road, Beltsville, MD, United States, 20705
Employees
info
43
Website
info
nextcure.com
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
Metrics
BasicAdvanced
Market cap
info
$22.7M
P/E ratio
info
-
EPS
info
-$25.97
Dividend Yield
info
0.00%
Beta
info
1.56
Forward P/E ratio
info
0
EBIDTA
info
$-61.2M
Ex dividend date
info
-
Price & volume
Market cap
info
$22.7M
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
9.52
Price to book
info
0.76
Earnings
EPS
info
-$25.97
EPS estimate (current quarter)
info
-$3.98
EPS estimate (next quarter)
info
-$4.07
EBITDA
info
$-61.2M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.56
52-week High
info
$18.68
52-week Low
info
$2.69
50-day moving average
info
$7.30
200-day moving average
info
$6.53
Short ratio
info
0.88
Short %
info
0.41%
Management effectiveness
ROE (TTM)
info
-105.88%
ROA (TTM)
info
-53.12%
Profit margin
info
0.00%
Gross profit margin
info
$-54.2M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
-100.00%
Share stats
Outstanding Shares
info
2.7M
Float
info
1.7M
Insiders %
info
14.79%
Institutions %
info
39.25%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$17.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.41
-$0.36
-13.89%
Q4 • 24Missed
-$0.39
-$0.40
2.50%
Q1 • 25Beat
-$11.29
-$0.43
-2,556.47%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-26.8M
-∞%
Q2 • 25
$-8.6M
0.00%
Q3 • 25
NaN%
-67.83%
0.00%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$47.7M
$16M
33.64%
Q2 • 25
$39.6M
$16M
40.31%
Q3 • 25
-16.93%
-0.47%
19.82%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-22.7M
$3.8M
$2M
$-22.7M
Q2 • 25
$-6.3M
-
-
$-6.3M
Q3 • 25
-72.40%
-
NaN%
-72.40%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a NextCure  Inc share?
Collapse

NextCure  Inc shares are currently traded for undefined per share.

How many shares does NextCure  Inc have?
Collapse

NextCure  Inc currently has 2.7M shares.

Does NextCure  Inc pay dividends?
Collapse

No, NextCure  Inc doesn't pay dividends.

What is NextCure  Inc 52 week high?
Collapse

NextCure  Inc 52 week high is $18.68.

What is NextCure  Inc 52 week low?
Collapse

NextCure  Inc 52 week low is $2.69.

What is the 200-day moving average of NextCure  Inc?
Collapse

NextCure  Inc 200-day moving average is $6.53.

Who is NextCure  Inc CEO?
Collapse

The CEO of NextCure  Inc is Michael S. Richman MSBA.

How many employees NextCure  Inc has?
Collapse

NextCure  Inc has 43 employees.

What is the market cap of NextCure  Inc?
Collapse

The market cap of NextCure  Inc is $22.7M.

What is the P/E of NextCure  Inc?
Collapse

The current P/E of NextCure  Inc is null.

What is the EPS of NextCure  Inc?
Collapse

The EPS of NextCure  Inc is -$25.97.

What is the PEG Ratio of NextCure  Inc?
Collapse

The PEG Ratio of NextCure  Inc is null.

What do analysts say about NextCure  Inc?
Collapse

According to the analysts NextCure  Inc is considered a buy.